South Shore dispensary gets provisional OK to sell recreational – The Patriot Ledger


M3 Ventures could become the first dispensary on the South Shore to make the dive into recreational sales.

BOSTON —  A Plymouth medical marijuana dispensary could be the first on the South Shore to make the dive into recreational sales.

The state Cannabis Control Commission on Thursday provisionally approved three licenses for M3 Ventures on Collins Avenue in Plymouth to begin growing and selling marijuana for non-medical use. The third license would allow it to make marijuana-infused products known as edibles.

M3 Ventures was one of the three entities provisionally granted licenses Thursday. Pharmacannis, a Wareham-based company, was granted a provisional retail license and I.N.S.A. Inc., based in Easthampton, was also granted provisional licenses to infuse, grow and sell non-medical marijuana. Both companies are already operating medical marijuana dispensaries in their respective towns.

M3 Ventures has another medical marijuana facility in Mashpee.

So far, the Cannabis Control Commission has approved seven retail marijuana licenses. The other retail locations that have received provisional licenses to sell are in Leicester, Amesbury, Northampton and Brookline.

All seven facilities must meet several conditions to earn their final licenses, including fingerprinting staff and demonstrating during inspection that they comply with state laws and regulations.

“It will probably be about two months until we can open,” said Kevin O’Reilly, chief operating officer of M3 Ventures and a Plymouth resident.

Though recreational sales will take place in the same building, the dispensary has to build a separate entryway and area for recreational sales, and ensure it has enough product to serve customers and patients, O’Reilly said.

Another factor is delaying recreational marijuana sales: The state has yet to license a laboratory to test the product. Marijuana must be tested for quality and impurities before it can be legally sold to customers.

“At our next meeting, hopefully we’ll

Read More Here...

Leave a comment

Your email address will not be published. Required fields are marked *